MediGus a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology.
Medigus Ltd., a medical device company, engages in the research and development of endoscopic procedures and devices. It offers the MUSE endoscopy system comprising surgical stapler, miniature camera, and ultrasound sensor sensor for the treatment of gastroesophageal reflux disease. The company was founded in 1999 and is based in Omer, Israel.
thank you for yore answer. i read that three investings companis in US buy MDGS shares,, Empery Asset Management SABBY MANAGEMENT Migdal Insurance & Financial Holdings Ltd
MDGS - MediGus Ltd: OPEN:24.60 DAY RANGE: 23.60 - 24.70 VOLUME: 1,185,640 PREVIOUS CLOSE: 24.20 52WK RANGE: 22.40 - 223.00 1 YR RETURN: -81.76% YTD RETURN: -52.68% EARNINGS PER SHARE (ILS) (TTM): -0.58 MARKET CAP (M ILS): 27.222 SHARES OUTSTANDING (M): 114.379 PRICE/SALES (TTM): 8.34 MDGS - MediGus Ltd News Headlines: 1: Medigus Regains Compliance With The Nasdaq Listing Requirements 2: Medigus Announces $7.5 Million Public Offering
On 23 Mar, ETHICON acquisition TORAX MEDICAL . On 27 Mar, Medigus raised $7.5 million on Nasdaq from US hedge fund and israeli investmet company. Do TORAX acquisition by ETHICON can create bullish impact on Medigus MDGS?
Hey Friends, Medigus is a medical device company, pioneer developer of the Medigus Ultrasonic Surgical Endostapler, or MUSE™ system, a unique proprietary endoscopic device for the treatment of gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. • Global GERD disease treatment market size set to touch $4 billion mark by FY20. • On Mar 23, 2017, ETHICON acquisition TORAX MEDICAL. TORAX MEDICAL developed the LINX device for GERD tretment. • LINX is not for everyone with advanced GERD!. LINX System Risks: Difficulty swallowing. Painful swallowing. Pain. Stomach Bloating. As i say,On Mar 23, 2017, ETHICON acquisition TORAX MEDICAL. On Mar 27, 2017 Medigus raised $7.5 million on Nasdaq! by Majeure hedge fund and investment companies. • Medigus MUSE™ system is more effective and with less Side Effects(no device needed). • Medigus is israeli company. • Medigus in middle of Majeure clinical trial in several Chinese hospitals + Chinese army hospital. • On Mar 21, 2017 Israeli Prime Minister, Mr Binyamin Netanyahu Meets with Chinese President Xi Jinpingi in China. • On Apr 6, 2017 President of the United States, Donald John Trump Meets with Chinese President Xi Jinpingi in China. • ETHICON acquisition TORAX MEDICAL • China Galaxy Investment Management president Wang Xuejun: "Chinese investment in Israeli tech is just beginning". $MDGS will Skyrocketed Higher.. my target is 9$! It's Time to make money!
